TitleAssistant Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Pediatrics
Address1102 BATES
Houston, TX 77030
vCardDownload vCard

    Collapse Biography 
    Collapse education and training
    Hacettepe University, Ankara, TurkeyDoctor of Medicine MD06/1998Medical School
    Rutgers New Jersey Medical School, Newark, NJPediatrics06/2008Residency
    Columbia University New York Presbyterian Medical Center, New York, NYPediatric Rheumatology09/2011Fellowship
    Collapse awards and honors
    2018 - 2019Best Teacher of the Year (2018 and 2019) by Pediatric Rheumatology Fellows, Nationwide Children's Hospital, Columbus, OH
    2017John Shulz Quality Improvement Award, Nationwide Children's Hospital, Columbus, OH
    2008 - 2009Consensus Treatment Plan (CTP) development and implementation, Columbia University, New York, NY

    Collapse Overview 
    Collapse overview
    Dr. Yildirim Toruner’s mission as a pediatric rheumatologist is to improve outcomes of care of children with rheumatic diseases and raise awareness about juvenile arthritis, lupus and other rare rheumatic diseases through better education of patients and families as well as other medical professionals. She strongly supports and practices shared decision-making strategies while taking care of her patients: each patient and family’s preferences for disease management, medication and treatment choices need to be addressed along with most recent scientific developments.

    Dr. Yildirim Toruner’s research interest is in quality improvement (QI) methods and patient-reported outcomes (PRO) measure development, validation, and implementation in clinical care. She is involved in multiple QI projects locally and nationally. She serves as the site Principle Investigator for the Pediatric Rheumatology Care and Outcomes Improvement Network ( This multi-hospital learning network brings together care teams with parents and patients, employing QI science to improve the outcomes of care of children with rheumatic disease.

    Dr. Yildirim Toruner is the current chair of the Implementation Science workgroup within Childhood Arthritis and Research Alliance (CARRA). Implementation Science is the scientific study of methods that promote the systematic uptake of research findings and other evidence-based practices into routine practice to improve the quality and effectiveness of health services. Integration of QI and Implementation approaches can support improved health outcomes and continuous learning.

    She is currently involved in CARRA as a group leader for CTP development in treatment of refractory Kawasaki Disease. She was previously involved in CTP development for treatment of lupus nephritis as well as treatment of PFAPA (periodic fever, aphthous stomatitis, pharyngitis and adenitis syndrome). She is working on implementation of CARRA CTPs by using implementation science methods.

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Brown RA, Barbar-Smiley F, Yildirim-Toruner C, Ardura MI, Ardoin SP, Akoghlanian S. Reintroduction of immunosuppressive medications in pediatric rheumatology patients with histoplasmosis: a case series. Pediatr Rheumatol Online J. 2021 Jun 07; 19(1):84. PMID: 34098976.
      Citations:    Fields:    
    2. Goh YI, Bullock DR, Taylor J, Pooni R, Lee TC, Vora SS, Yildirim-Toruner C, Morgan EM, Pan N, Harris JG, Warmin A, Wiegand K, Burnham JM, Barbar-Smiley F. Exploring Pediatric Tele-Rheumatology Practices During COVID-19: A Survey of the PRCOIN Network. Front Pediatr. 2021; 9:642460. PMID: 33748049.
    3. Amarilyo G, Rothman D, Manthiram K, Edwards KM, Li SC, Marshall GS, Yildirim-Toruner C, Haines K, Ferguson PJ, Lionetti G, Cherian J, Zhao Y, DeLaMora P, Syverson G, Nativ S, Twilt M, Michelow IC, Stepanovskiy Y, Thatayatikom A, Harel L, Akoghlanian S, Tucker L, Marques MC, Srinivasalu H, Propst EJ, Licameli GR, Dedeoglu F, Lapidus S. Consensus treatment plans for periodic fever, aphthous stomatitis, pharyngitis and adenitis syndrome (PFAPA): a framework to evaluate treatment responses from the childhood arthritis and rheumatology research alliance (CARRA) PFAPA work group. Pediatr Rheumatol Online J. 2020 Apr 15; 18(1):31. PMID: 32293478.
      Citations: 5     Fields:    Translation:Humans
    4. Sivaraman V, Wise KA, Cotton W, Barbar-Smiley F, AlAhmed O, MacDonald D, Lemle S, Yildirim-Toruner C, Ardoin SP, Ardura MI. Previsit Planning Improves Pneumococcal Vaccination Rates in Childhood-Onset SLE. Pediatrics. 2020 01; 145(1). PMID: 31879277.
      Citations:    Fields:    Translation:HumansPHPublic Health
    5. Jaggi P, Grcic M, Kovalchin J, Wilhelm CM, Yildirim-Toruner C, Texter K. Using the Electronic Medical Record to Correlate Kawasaki Disease Phenotypes With Clinical Outcomes. J Pediatric Infect Dis Soc. 2018 May 15; 7(2):119-123. PMID: 28383697.
      Citations: 1     Fields:    Translation:Humans
    6. Boneparth A, Radhakrishna SM, Greenbaum LA, Yen E, Okamura DM, Cooper JC, Mason S, Levy DM, Sule SD, Jensen PT, Yildirim-Toruner C, Ardoin SP, Wenderfer SE. Approach to Membranous Lupus Nephritis: A Survey of Pediatric Nephrologists and Pediatric Rheumatologists. J Rheumatol. 2017 Nov; 44(11):1619-1623. PMID: 28916546.
      Citations: 2     Fields:    Translation:Humans
    7. Costa-Reis P, Nativ S, Isgro J, Rodrigues T, Yildirim-Toruner C, Starr A, Saiman L, Imundo L, Eichenfield A. Major infections in a cohort of 120 patients with juvenile-onset systemic lupus erythematosus. Clin Immunol. 2013 Dec; 149(3):442-9. PMID: 24211846.
      Citations: 7     Fields:    Translation:Humans
    8. Mina R, von Scheven E, Ardoin SP, Eberhard BA, Punaro M, Ilowite N, Hsu J, Klein-Gitelman M, Moorthy LN, Muscal E, Radhakrishna SM, Wagner-Weiner L, Adams M, Blier P, Buckley L, Chalom E, Chédeville G, Eichenfield A, Fish N, Henrickson M, Hersh AO, Hollister R, Jones O, Jung L, Levy D, Lopez-Benitez J, McCurdy D, Miettunen PM, Quintero-del Rio AI, Rothman D, Rullo O, Ruth N, Schanberg LE, Silverman E, Singer NG, Soep J, Syed R, Vogler LB, Yalcindag A, Yildirim-Toruner C, Wallace CA, Brunner HI. Consensus treatment plans for induction therapy of newly diagnosed proliferative lupus nephritis in juvenile systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2012 Mar; 64(3):375-83. PMID: 22162255.
      Citations: 47     Fields:    Translation:Humans
    9. Yildirim-Toruner C, Diamond B. Current and novel therapeutics in the treatment of systemic lupus erythematosus. J Allergy Clin Immunol. 2011 Feb; 127(2):303-12; quiz 313-4. PMID: 21281862.
      Citations: 49     Fields:    Translation:Humans
    10. Yildirim-Toruner C, Kimura Y, Rabinovich E. Hodgkin's lymphoma and tumor necrosis factor inhibitors in juvenile idiopathic arthritis. J Rheumatol. 2008 Aug; 35(8):1680-1. PMID: 18671328.
      Citations: 10     Fields:    Translation:Humans
    11. Husain S, Yildirim-Toruner C, Rubio JP, Field J, Schwalb M, Cook S, Devoto M, Vitale E. Variants of ST8SIA1 are associated with risk of developing multiple sclerosis. PLoS One. 2008 Jul 09; 3(7):e2653. PMID: 18612409.
      Citations: 5     Fields:    Translation:Humans
    12. Yildirim-Toruner C, Subramanian K, El Manjra L, Chen E, Goldstein S, Vitale E. A novel frameshift mutation of FOXC2 gene in a family with hereditary lymphedema-distichiasis syndrome associated with renal disease and diabetes mellitus. Am J Med Genet A. 2004 Dec 15; 131(3):281-6. PMID: 15523639.
      Citations: 10     Translation:HumansCells
    Click the
    buttons for more information and interactive visualizations!
    Concepts (100)
    Co-Authors (2)
    Similar People (60)
    Same Department Expand Description